Skip to main content
. 2021 Jan 28;10(2):121. doi: 10.3390/antibiotics10020121

Figure 2.

Figure 2

Number of observed and predicted human Salmonella isolates, Greece, 2006–2017; (a) Number of observed and predicted human S. Enteritidis isolates according to the model used, Greece, 2006–2017; (b) Number of observed and predicted human S. Enteritidis isolates according to the model used, Greece, 2006–2015 (For S. Enteritidis, a sensitivity analysis was also performed for both periods 2006–2017 and 2006–2015. The reason was that in 2016 there was an excess in the number of S. Enteritidis cases in Greece probably attributed to the multi-country S. Enteritidis outbreak related to the consumption of infected Polish eggs); (c) Number of observed and predicted human S. Typhi-murium isolates according to the model used, Greece, 2006–2017; (d) Number of observed and predicted human isolates attributed to “Control Salmonella serotypes” (serotypes detected from human cases between 2004 and 2017, but were either not detected or rarely detected, the maximum of two times each, in poultry) according to the model used, Greece, 2006–2017.